Partner with us

Maximising our vision through sustainable, successful partnerships

At HRA Pharma Rare Diseases, we believe that collaboration is essential to further our understanding of rare and ultra-rare diseases and to bring the latest innovations to these underserved communities. Through meaningful and long-lasting partnerships, we have strengthened our commitment to addressing the global and international unmet needs and challenges faced by people living with rare disease, like Cushing’s syndrome and Adrenocortical Carcinoma (ACC), today.

HRA Pharma Rare Diseases: A continuous successful story


HRA Pharma Rare Diseases is a global company dedicated to bringing life-saving medicines to people living with some of the world’s rarest diseases. Our scientific areas of focus are rare endocrine diseases, including Cushing’s syndrome, Adrenocortical Carcinoma (ACC) and other ultra-rare and rare diseases.

As experts in rare and ultra-rare endocrine and malignant diseases we are passionate about improving the lives of people living with Cushing’s syndrome and Adrenocortical Carcinoma (ACC). We are market leaders, providing access to three leading treatments for patients with Cushing’s syndrome and advanced Adrenocortical Carcinoma (ACC), as well as a blood monitoring service for patients with Adrenocortical Carcinoma (ACC) in Europe.

We have created a network of local and regional partners across 5 continents by partnering with scientific organisations, patients' associations, university hospitals and worldwide investigators, globally, to access the latest research and innovations, in order to bring the best patient care to the forefront of the community.

Why partner with us?


Trusted Partner:

Highly experienced in acquiring and growing rare product portfolios around the world, and can partner with you on a country-by-country, regional or global basis as needed.


Global footprint:

We have an established network of affiliates and partnerships spanning multiple continents, which provide the maximal coverage to patients worldwide, with continuing geographic expansion.


In-house expertise:

We are a Global Integrated Organization with of over 50 employees led by a highly professional management team



We welcome partnerships with external organizations who share in our vision to transform the lives of patients worldwide. We are looking to partner with companies, research organizations, academia, and non-profit organizations, to create mutually beneficial relationships that drive research and innovation, maximize the potential, and reach of our treatments and initiatives worldwide, and enter new markets.
Together, we make the lack of awareness around rare diseases even rarer because no patient should be left behind!

Contact us to discuss how together we can shape the future of rare diseases